Firstly, activation of RLRs by their specific ligands not only triggers antitumor immunity via IFN-dependent effector T cells and NK cells activation, but also can directly induce apoptosis of tumor cells in an IFN-independent manner. Here, IFNA1 is linked to neoplasm.